News
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder.
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results